Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

NCT06238648

Conditions
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Siteman Cancer Center at Washington University St Louis, Missouri, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor

NCT06615193

Conditions
Advanced Solid Tumors, Hematologic Diseases, Hematologic Neoplasms, +11 more
Locations
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
  • The Second Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China
View Trial Details
Recruiting

Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia

NCT06607419

Conditions
B-Cell Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Anhui Provincial Children's Hospital Hefei, Anhui, China
  • Fujian Children's Hospital Fuzhou, Fujian, China
  • Shanghai Children's Medical center Shanghai, Shanghai Municipality, China
  • Ningbo Women and Children's Hospital Ningbo, Zhejiang, China
View Trial Details
Recruiting

CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms

NCT06593145

Conditions
Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego - Centralny Szpital Kliniczny Warsaw, Ul. Banacha 1a, Poland
  • Uniwersyteckie Centrum Kliniczne Gdańskiego Uniwersytetu Medycznego - Katedra i Klinika Hematologii i Transplantologii Gdansk, Ul. Smoluchowskiego 17, Poland
View Trial Details
Recruiting

Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia

NCT06450067

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details

Related conditions